# Towards making immunization programmes in Africa more successful: a primer on implementation research

**Authors:** Abdu Abdullahi Adamu, Chukwudi Arnest Nnaji, Echezona Edozie Ezeanolue, Charles Shey Wiysonge

PMC · DOI: 10.11604/pamj.supp.2025.51.1.46919 · The Pan African Medical Journal · 2025-06-13

## TL;DR

This paper explains how implementation research can help improve vaccination programs in Africa by addressing local barriers with practical solutions.

## Contribution

The paper introduces a primer on implementation research tailored for African immunization decision-makers and implementers.

## Key findings

- Implementation research can identify and address contextual barriers to vaccination in Africa.
- Integration of implementation research into immunization programs can lead to sustainable and practical solutions.
- The primer aims to guide decision-makers in leveraging implementation research for program success.

## Abstract

There is a protracted lag in efforts to widen access and uptake of routine vaccination services in Africa. As a result, vaccine-preventable diseases continue to remain a major public health challenge. The increasing adoption of implementation research in global health is an opportunity for immunization programmes to leverage new tools in tackling long-standing implementation barriers to vaccination efforts. Implementation research in immunization programmes can strengthen how contextual barriers hindering vaccination efforts are identified and addressed with sustainable, context-appropriate, and practical strategies. In this primer, which is targeted at country-level immunization decision-makers and implementers, we discussed the meaning of implementation research and the value addition it can bring in fast-tracking programmatic success when integrated into all aspects of the immunization landscape.“

## Full-text entities

- **Diseases:** malaria (MESH:D008288), rotavirus (MESH:D012400), diphtheria (MESH:D004165), VPD (MESH:D000079263), Pneumoniae (MESH:D011014), tuberculosis (MESH:D014376), measles (MESH:D008457), DALY (MESH:D000275), COVID-19 (MESH:D000086382), Streptococcus pneumoniae (MESH:D011008), deaths (MESH:D003643), Disease (MESH:D004194)
- **Chemicals:** MCV2 (-)
- **Species:** Streptococcus pneumoniae (species) [taxon 1313], Klebsiella pneumoniae (species) [taxon 573], Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12595557/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12595557/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12595557/full.md

---
Source: https://tomesphere.com/paper/PMC12595557